Skip navigation

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

URL of this page: https://medlineplus.gov/genetics/gene/aldh3a2/

ALDH3A2 gene

aldehyde dehydrogenase 3 family member A2

Normal Function

The ALDH3A2 gene is a member of the aldehyde dehydrogenase (ALDH) gene family. Genes in this family provide instructions for producing enzymes that alter molecules called aldehydes. The ALDH3A2 gene provides instructions for making an enzyme called fatty aldehyde dehydrogenase (FALDH). This enzyme is involved in the breakdown of fats, specifically the breakdown of molecules called fatty aldehydes to fatty acids. This conversion of molecules is part of a multistep process called fatty acid oxidation in which fats are broken down and converted into energy.

The FALDH enzyme is found in most tissues, but its activity (expression) is highest in the liver. Within cells, the FALDH enzyme is located in the endoplasmic reticulum, a structure involved in protein processing and transport.

Health Conditions Related to Genetic Changes

Sjögren-Larsson syndrome

At least 80 mutations in the ALDH3A2 gene have been found to cause Sjögren-Larsson syndrome, a condition characterized by dry, scaly skin (ichthyosis); neurological abnormalities; and eye problems. Many of these mutations change single protein building blocks (amino acids) in the FALDH enzyme. The gene mutations that cause Sjögren-Larsson syndrome lead to the production of a FALDH enzyme that is unable to break down fatty aldehyde molecules. As a result, fats that are not broken down can build up in cells. In all affected tissues, excess fat accumulation interferes with the normal formation of protective membranes or materials that are necessary for the body to function normally. These abnormalities underlie the characteristic signs and symptoms of Sjögren-Larsson syndrome.

More About This Health Condition

Other Names for This Gene

  • AL3A2_HUMAN
  • aldehyde dehydrogenase 10
  • aldehyde dehydrogenase 3 family, member A2
  • aldehyde dehydrogenase family 3 member A2
  • ALDH10
  • FALDH
  • fatty aldehyde dehydrogenase
  • microsomal aldehyde dehydrogenase

Additional Information & Resources

Tests Listed in the Genetic Testing Registry

Scientific Articles on PubMed

Catalog of Genes and Diseases from OMIM

Gene and Variant Databases

References

  • Ashibe B, Motojima K. Fatty aldehyde dehydrogenase is up-regulated by polyunsaturated fatty acid via peroxisome proliferator-activated receptor alpha and suppresses polyunsaturated fatty acid-induced endoplasmic reticulum stress. FEBS J. 2009 Dec;276(23):6956-70. doi: 10.1111/j.1742-4658.2009.07404.x. Epub 2009 Oct 27. Citation on PubMed
  • Rizzo WB, S'Aulis D, Jennings MA, Crumrine DA, Williams ML, Elias PM. Ichthyosis in Sjogren-Larsson syndrome reflects defective barrier function due to abnormal lamellar body structure and secretion. Arch Dermatol Res. 2010 Aug;302(6):443-51. doi: 10.1007/s00403-009-1022-y. Epub 2010 Jan 5. Citation on PubMed or Free article on PubMed Central
  • Rizzo WB. Sjogren-Larsson syndrome: molecular genetics and biochemical pathogenesis of fatty aldehyde dehydrogenase deficiency. Mol Genet Metab. 2007 Jan;90(1):1-9. doi: 10.1016/j.ymgme.2006.08.006. Epub 2006 Sep 22. Citation on PubMed or Free article on PubMed Central

The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.